Stellar

Stellar

The purpose of this study is to evaluate the efficacy and safety of Sotatercept plus background PAH therapy at 24 weeks in adults with pulmonary arterial hypertension (PAH).

Please use this link for further information:

Primary Investigator: Peter Engel

Follow up only

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative